# US 2008/0305157 A1 · Encapsulation and separation of charged organic solutes inside catanionic vesicles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305157 A1
- Document ID: US20080305157A1
- Status: Published application
- Kind: A1
- Application number: 12/155,758
- Filed: 2008-06-09
- Published: 2008-12-11
- Earliest claimed: 2007-06-08
- Assignees: University of Maryland Office of Technology Commercialization
- Inventors: Douglas S. English; Srinivasa Raghavan; Philip R. DeShong; Xiang Wang; Emily J. Danoff; Jaeho Lee
- Web page: https://patentgrep.com/patent/US20080305157A1

## CPC

- A61K 9/1272: comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543})
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Catanionic vesicles including solute ion, methods for forming these, and methods of using these.

## Claims

### Claim 1

A method for sequestering a solute ion within a catanionic vesicle comprising:
determining the charge of the solute ion;
creating a catanionic vesicle having a net surface charge opposite to the charge of the solute ion;
combining the catanionic vesicle with the solute ion; and
allowing the catanionic vesicle to sequester the solute ion.

### Claim 2 (depends on 1)

The method of claim 1, wherein the solute ion is in solution, comprising:
adding a cationic surfactant and an anionic surfactant to the solution, in a ratio effective to produce the catanionic vesicles.

### Claim 3 (depends on 2)

The method of claim 2, wherein the solute ion is selected from the group consisting of a biologically active compound, a pharmaceutical agent, a fluorescently active chemical, a cosmetic chemical, an agriculturally active chemical, a fertilizer, a nutrient, a pesticide, an herbicide, and combinations.

### Claim 4 (depends on 1)

The method of claim 1, wherein the solute ion is in a bulk solution, and the catanionic surfactant vesicle comprises a bilayer comprising a cationic surfactant and an anionic surfactant, and an inner pool separated from the bulk solution by the bilayer, the method comprising:
combining the catanionic surfactant vesicle with the bulk solution and sequestering the solute ion in the inner pool and/or the bilayer of the catanionic vesicle, and
separating the solute ion from the bulk solution by separating the catanionic surfactant vesicle from the bulk solution.

### Claim 5 (depends on 4)

The method of claim 4, wherein the solute ion is selected from the group consisting of an atomic ion, a charged inorganic molecule, and a charged organic molecule.

### Claim 6 (depends on 4)

The method of claim 4 wherein the separating comprises size exclusion chromatography, affinity chromatography, and/or electrokinetic chromatography.

### Claim 7

An aqueous composition, comprising,
an aqueous environment and a catanionic surfactant vesicle,
the catanionic surfactant vesicle comprising
a bilayer comprising a cationic surfactant and an anionic surfactant and having a net surface charge;
an inner pool separated from the aqueous environment by the bilayer;
a solute ion having a charge, within the inner pool and/or the bilayer;
the net surface charge of the bilayer being opposite to that of the solute ion.

### Claim 8 (depends on 7)

The aqueous composition of claim 7, wherein the solute ion is selected from the group consisting of a metal, carboxyfluorescein, Lucifer yellow, Rhodamine 6G, Sulforhodamine 101, a drug, doxorubicin, a chemotherapeutic agent, a natural product, a peptide, an oligopeptide, a polypeptide, a nucleotide, an oligonucleotide, a polynucleotide, DNA, RNA, derivatives of these, and combinations.

### Claim 9 (depends on 7)

The aqueous composition of claim 7, wherein the anionic surfactant is selected from the group consisting of alkyl sulfate, sodium octyl sulfate, sodium decyl sulfate, sodium dodecyl sulfate, sodium tetra-decyl sulfate, alkyl sulfonates, sodium octyl sulfonate, sodium decyl sulfonate, sodium dodecyl sulfonate, alkyl benzene sulfonates, sodium octyl benzene sulfonate, sodium decyl benzene sulfonate, sodium dodecyl benzene sulfonate, fatty acid salt, sodium octanoate, sodium decanoate, sodium dodecanoate, sodium salt of oleic acid, derivatives of these, and combinations.

### Claim 10 (depends on 7)

The aqueous composition of claim 7, wherein the cationic surfactant is selected from the group consisting of alkyl trim ethylammonium halide, octyl trimethylammonium bromide, decyl trimethylammonium bromide, dodecyl trimethylammonium bromide, myristyl trimethylammonium bromide, cetyl trimethylammonium bromide, alkyl trimethylammonium tosylate, octyl trimethylammonium tosylate, decyl trimethylammonium tosylate, dodecyl trimethylammonium tosylate, myristyl trimethylammonium tosylate, cetyl trimethylammonium tosylate, N-alkyl pyridinium halide, decyl pyridinium chloride, dodecyl pyridinium chloride, cetyl pyridinium chloride, derivatives of these and combinations.

### Claim 11 (depends on 7)

The aqueous composition of claim 7, wherein the cationic and/or the anionic surfactant is selected from the group consisting of SDS, DTAC, DTAB, DPC, DDAO, DDAB, SOS, AOT, derivatives of these, and combinations.

### Claim 12 (depends on 7)

The aqueous composition of claim 7, wherein the cationic surfactant is a single alkyl chain surfactant and/or the anionic surfactant is a single alkyl chain surfactant.

### Claim 13 (depends on 7)

The aqueous composition of claim 7,
wherein the solute ion is a cation having positive charge and
wherein the cationic surfactant and anionic surfactant comprising the bilayer are in proportions creating a bilayer with a negative net surface charge.

### Claim 14 (depends on 7)

The aqueous composition of claim 7,
wherein the solute ion is an anion having negative charge and
wherein the cationic surfactant and anionic surfactant comprising the bilayer are in proportions creating a bilayer with a positive net surface charge

### Claim 15 (depends on 7)

The aqueous composition of claim 7,
wherein the bilayer comprises cationic surfactant and anionic surfactant in a molar ratio in a range of from about 1:9 to about 9:1, excluding a molar ratio of about 1:1.

### Claim 16 (depends on 7)

The aqueous composition of claim 7, wherein the combined weight percentage of cationic surfactant and anionic surfactant in the external aqueous environment is less than about 5 wt %.

### Claim 17 (depends on 7)

The aqueous composition of claim 7, wherein the combined weight percentage of cationic surfactant and anionic surfactant in the external aqueous environment is less than from about 0.0001 wt % to about 3 wt %.

### Claim 18 (depends on 7)

The aqueous composition of claim 7, wherein the combined weight percentage of cationic surfactant and anionic surfactant in the external aqueous environment is from about 0.5 wt % to about 2 wt %.

### Claim 19 (depends on 7)

The aqueous composition of claim 7, wherein the concentration of the solute ion within the catanionic vesicle is greater than the concentration of the solute ion in the aqueous environment.

### Claim 20 (depends on 7)

The aqueous composition of claim 7, wherein the encapsulation efficiency of the solute ion in the vesicle is at least about 2%.

### Claim 21 (depends on 7)

The aqueous composition of claim 7, wherein the percentage of solute adsorbed on the bilayer is at least about 0.5%.

### Claim 22

A method of introducing an agent into a cell, comprising:
contacting the cell with a composition comprising catanionic surfactant vesicles comprising a bilayer of a cationic surfactant and an anionic surfactant defining an inner pool comprising the agent, the net surface charge of the bilayer being opposite to that of the agent.

### Claim 23 (depends on 22)

The method of claim 22, wherein the cell is within a living organism.

### Claim 24 (depends on 22)

The method of claim 22, wherein the composition comprising the catanionic surfactant vesicles is administered orally or intravenously.

### Claim 25

A method of introducing a nucleic acid into a cell, comprising:
administering catanionic surfactant vesicles comprising a nucleic acid to the cell,
wherein the catanionic surfactant vesicle comprises
a bilayer comprising a cationic surfactant and an anionic surfactant,
an inner pool separated from an aqueous environment by the bilayer,
the inner pool and/or the bilayer comprising the nucleic acid,
the nucleic acid having a negative charge,
the cationic surfactant and anionic surfactant comprising the bilayer having a net positive surface charge.

### Claim 26

A kit, comprising:
a premeasured amount of an anionic surfactant in a first labeled container; and
a premeasured amount of a cationic surfactant in a second labeled container,
wherein the premeasured amount of the anionic surfactant and the premeasured amount of the cationic surfactant are selected so that when the premeasured amount of the anionic surfactant and the premeasured amount of the cationic surfactant are added to a predetermined amount of water containing a solute ion having a charge, catanionic surfactant vesicles are formed and
wherein the catanionic surfactant vesicles comprise
a bilayer comprising a cationic surfactant and an anionic surfactant and having a net surface charge,
an inner pool separated from the aqueous environment by the bilayer,
the solute ion within the inner pool and/or the bilayer, and
the net surface charge of the bilayer being opposite to that of the solute ion.

### Claim 27

A kit, comprising:
a mixture of an anionic surfactant and a cationic surfactant in a labeled container,
wherein the anionic surfactant and the cationic surfactant are in a predetermined molar ratio in the mixture,
wherein the predetermined molar ratio is selected so that when the mixture is added to a predetermined amount of water containing a solute ion having a charge, catanionic surfactant vesicles are formed and
wherein the catanionic surfactant vesicles comprise
a bilayer comprising a cationic surfactant and an anionic surfactant and having a net surface charge,
an inner pool separated from the aqueous environment by the bilayer,
the solute ion within the inner pool and/or the bilayer, and
the net surface charge of the bilayer being opposite to that of the solute ion.

### Claim 28

A kit, comprising:
a mixture of an anionic surfactant, a cationic surfactant, and a solute ion having a charge in a labeled container,
wherein the anionic surfactant and the cationic surfactant are in a predetermined molar ratio in the mixture,
wherein the predetermined molar ratio is selected so that when the mixture is added to a predetermined amount of water, catanionic surfactant vesicles are formed and
wherein the catanionic surfactant vesicles comprise
a bilayer comprising a cationic surfactant and an anionic surfactant and having a net surface charge,
an inner pool separated from the aqueous environment by the bilayer,
the solute ion within the inner pool and/or the bilayer, and
the net surface charge of the bilayer being opposite to that of the solute ion.
